DB
COLL icon

Danske Bank’s Collegium Pharmaceutical COLL Stock Holding History

Danske Bank’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16,926
Closed -$654K – 1465
2024
Q3 		$654K Buy
+16,926
New +$604K ﹤0.01% 878
2024
Q2 		– Sell
-58,708
Closed -$2.28M – 1173
2024
Q1 		$2.28M Buy
+58,708
New +$2.05M 0.01% 667

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Danske Bank's COLL Position: Q4 2024 in Review

Danske Bank sold out of Collegium Pharmaceutical (COLL) in Q4 2024, closing a stake of 16,926 shares — an estimated $654K sold.

Danske Bank first reported a position in COLL in Q1 2024 and held it in 2 quarters. The position peaked at $2.28M in Q1 2024. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

  • Danske Bank reported no remaining Collegium Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Danske Bank sold 16,926 Collegium Pharmaceutical shares in Q4 2024, an estimated $654K.
  • Danske Bank first reported a position in Collegium Pharmaceutical in Q1 2024 and held it in 2 quarters.
  • Danske Bank's Collegium Pharmaceutical position peaked at $2.28M in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.